Pushkar Pharmaceuticals Pvt Ltd - Due diligence report

A 360° intelligence report on Pushkar Pharma: trust score, financial health, credit view, compliance, directors, growth and distress signals…

1993-03-03 U T, Chandigarh Active Unlisted Active Non-Compliant
Share
Connect MCP
PP Pushkar Pharmaceuticals Pvt Ltd
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Pushkar Pharma — 360° Intelligence Report

Generated from MCA filings & public records
80/100
Trust Score
Low Risk

Pushkar Pharma is assessed as Low Risk with a Trust Score of 80/100. Pushkar Pharma is an active private limited indian non-government company incorporated in 1993, operating in the Pharma sector. Reported revenue has declined across its recent filed years. It reported a loss in its latest filed year. Based on MCA filings and public records, it currently shows a low compliance risk and moderate financial risk profile.

Report generated on 07 Aug 2026 from the latest processed filings. Pushkar Pharmaceuticals Pvt Ltd snapshot & full profile →

Financial Health › Strong
Overall Assessment CautionWeakNeutralGoodStrong Strong
Compliance › Strong

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreLow Risk
80/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreLow Risk
80/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreModerate
70/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreCaution Indicated
45/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
95/100
Board strength, DIN status, churn and network.
Growth ScoreModerate
50/100
Revenue, profit, asset and hiring momentum.
Distress ScoreLow Risk
75/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 5 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 45/100 Caution Indicated
  • Negative operating earnings - debt service depends on external support.
  • Open charges exceed net worth - secured lenders rank ahead.
  • Moderate gearing (D/E 38%).
  • Working-capital cover adequate.

Charges position: 5 open (95.75 Lakh) · 0 satisfied (-).

Banking relationships (from registered charges)
LenderChargesAmount
Canara Bank3 48.0 cr
The Haryana Financial Corp.2 48.0 cr
Compliance Score: 80/100 Low Risk
  • Company status is Active as per MCA.
  • Marked ACTIVE non-compliant (INC-22A).
  • Annual filings current (balance sheet Mar 2025).
05

Director Intelligence

Stability score: 95/100
NameDIN / PANDesignationAppointedTenureDIN status
NEEL KAMAL SHARMA 01234567 Director 01/04/2018 6 yrs Approved
CHANDER SHEIKHER PUSHKARNA 01234567 Director 01/04/2018 6 yrs Approved
  • 2 directors on the board.
  • No disqualified or deactivated DINs.
  • Stable board - no exits in 3 years.
  • Average tenure above 5 years.
06

Ownership & Group Intelligence

As per FY 2021 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
-

Promoters hold the largest single block of equity - exact percentages are part of the full report.

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 50 · Distress 75
Growth signals & trust indicators
Latest year revenue grew 1.42.
Operating for 33+ years.
Distress signals & risk flags
Losses deepening year-on-year.
5 open charge(s) registered - assets are encumbered.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence78/100
Favourable indicators
Suitability as a supplier / customer counterparty.
  • Statutory record is clean.
  • 1 distress signal(s) - see Risk Center.
  • Financial filings available for verification.
Banker assessment61/100
Mixed indicators - deeper appraisal suggested
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • 5 open charge(s) of 95.75 Lakh already registered.
  • Compliance record supports lending.
Investor view64/100
Mixed indicators
Growth quality and scalability through an investor lens.
  • 1 growth signal(s) detected.
  • Margin and return trends computable from filings.
  • Management team looks stable.
09

MCA Filings & Events Timeline

Latest 9 events
30 Sep 2025
Last AGM held
Annual general meeting
31 Mar 2025
Latest balance sheet
Filed with ROC
26 Jun 1996
Charge created
Canara Bank - 58.25 Lakh
18 Apr 1996
Charge created
The Haryana Financial Corp. - 10.75 Lakh
31 Mar 1995
Charge created
Canara Bank - 8.00 Lakh
18 Apr 1994
Charge created
The Haryana Financial Corp. - 10.75 Lakh
03 Mar 1993
Incorporated
Registered with Roc Chandigarh
Director appointed
NEEL KAMAL SHARMA (Director)
Director appointed
CHANDER SHEIKHER PUSHKARNA (Director)
10

Key Observations

Auto-generated from the data above
Revenue declined 2.1x over the last 4 financial year(s).
Debt-to-equity stands at 24% - manageable leverage.
Net worth is positive.
Compliance record is strong - status, filings and flags are clean.
2 active director(s) / partner(s); board looks stable and experienced.
Promoters hold the largest single block of equity as per the FY 2021 annual return.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Paras Drugs Private Limited U24231HR1992PTC093761 Panchkula, Haryana, India
Maithili Pharma Private Limited U24299TG2020PTC146016 Hyderabad, Telangana, India
Aniket Pharma Private Limited U24111GJ2006PTC048288 Kalol, Gujarat, India
Admak Pharmaceuticals Private Limited U24100MH2015PTC266651 Mumbai, Maharashtra, India
Phages Pharmaceutical Private Limited U85300UP2019PTC118354 Prayagraj, Uttar Pradesh, India
Lifelong Biological Private Limited U24239KA2007PTC043662 Bangalore South, Karnataka, India
Susheeflex Polymers Private Limited U25190KA2015PTC083121 Bangalore, Karnataka, India
Sanil Pharmaceuticals Private Limited U24239KA1989PTC010426 Bengaluru, Karnataka, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Pushkar Pharma before audits and certifications: compliance score 80/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Pushkar Pharma: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Mixed indicators - deeper appraisal suggested. Credit risk score 45/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Mixed indicators. Growth score 50/100, margin trends, ownership structure and peer set for Pushkar Pharma - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Favourable indicators. Trust score 80/100, distress signals and MSME payment-delay disclosures - know whether Pushkar Pharma pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Pushkar Pharma - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Pushkar Pharma an active company?

Pushkar Pharma has MCA status “Active” with a compliance score of 80/100 (Low Risk).

Is Pushkar Pharma financially healthy?

Pushkar Pharma has a Financial Health Score of 70/100 (Moderate) based on its filed financial statements.

Should I do business with Pushkar Pharma?

Its overall Trust Score is 80/100 (Low Risk). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Pushkar Pharma?

Promoters hold the largest single block of equity - exact percentages are in the full report. 2 active director(s) are on record.

Does Pushkar Pharma have loans or charges against its assets?

5 open charge(s) are registered against its assets.

Is Pushkar Pharma up to date with its ROC filings?

Marked ACTIVE non-compliant (INC-22A). Overall compliance score: 80/100 (Low Risk).

Is it risky to lend to Pushkar Pharma?

Its Credit Risk Score is 45/100 (Caution Indicated). Banker verdict: Mixed indicators - deeper appraisal suggested.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.